NCT01356901 Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients Status COMPLETED Phase N/A
NCT01354431 BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE2
NCT01351480 Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients Status COMPLETED Phase PHASE3
NCT01348061 Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls Status COMPLETED Phase N/A
NCT01340586 Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis Status COMPLETED Phase PHASE1
NCT01337479 A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials Status COMPLETED Phase N/A
NCT01335698 Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients Status COMPLETED Phase PHASE3
NCT01335399 Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01333878 Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage Status COMPLETED Phase PHASE2/PHASE3
NCT01332227 Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients Status COMPLETED Phase PHASE4
NCT01331525 The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01323517 Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity Status COMPLETED Phase PHASE2
NCT01309945 Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression Status COMPLETED Phase PHASE2
NCT01309932 Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin Status COMPLETED Phase PHASE2
NCT01307488 Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy Status COMPLETED Phase PHASE4
NCT01306942 Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01294436 Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01294423 Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3